Form 4 for BSX Boston Scientific
Accepted 2024-02-22 00:00:00 ET · period of report 2024-02-20 · accession 0001225208-24-002706 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-02-22 | 2024-02-20 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | I - Discretionary | $66.22 | -68.0K | 0 | -100% | -$4.50M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | I | D | 67,974 | $66.22 | 0 | I By 401(k) | — | — | (F2) Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan prior to the rebalance election by the reporting person. |